UPDATE 1-Vaxcyte shares surge as pneumococcal vaccine succeeds in late-stage trial

3

(Updates shares in paragraph 1, adds analysts' comment in bullets 5 and 8) By Siddhi Mahatole Oct 5 (Reuters) – Vaxcyte said on Monday its experimental pneumococcal vaccine generated immune responses

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)